Vizsgálati helyszín
Phoenix
Phoenix, Arizona 85054, Egyesült ÁllamokMég nincs intézményhez kötve
- 12futó vizsgálat
- 10lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 22 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis14 vizsgálat
- 2. fázis4 vizsgálat
- 1/2. fázis2 vizsgálat
- 2/3. fázis1 vizsgálat
- Állapot
- Lezárult10 vizsgálat
- Toboroz7 vizsgálat
- Fut, nem toboroz5 vizsgálat
- Fő szponzor
- GlaxoSmithKline16 vizsgálat
- ViiV Healthcare4 vizsgálat
- Tesaro, Inc.2 vizsgálat
Futó vizsgálatok
Toboroz
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
NCT07805707· 3. fázis· GlaxoSmithKline· Forrás
Contact: Brock Merritt (principal investigator)
Toboroz
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
NCT07650916· 3. fázis· ViiV Healthcare· Forrás
Contact: Douglas Cunningham (principal investigator)
Toboroz
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
NCT07519395· 2. fázis· GlaxoSmithKline· Forrás
Contact: Reem Haddad (principal investigator)
Toboroz
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
NCT07201051· 2. fázis· GlaxoSmithKline· Forrás
Contact: Da-Wei Liao (principal investigator)
Toboroz
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
NCT06990880· 1/2. fázis· GlaxoSmithKline· Forrás
Contact: Yousef Zakharia (principal investigator)
Toboroz
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
NCT06679101· 3. fázis· GlaxoSmithKline· Forrás
Contact: Udit Yadav (principal investigator)
Toboroz
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698· 2. fázis· GlaxoSmithKline· Forrás
Contact: Moises Nevah Rubin (principal investigator)
Fut, nem toboroz
A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
NCT05371080· 3. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
NCT03981796· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
NCT03602859· 3. fázis· Tesaro, Inc.· Forrás
Fut, nem toboroz
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
NCT03299049· 3. fázis· ViiV Healthcare· Forrás
Fut, nem toboroz
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
NCT02951052· 3. fázis· ViiV Healthcare· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Hibát jelzek